"The COVID pandemic has highlighted the need to increase vaccination in Africa"
Signature(s)
Amount (.*)
€ 4,750,000
Sector(s)
Industry
: € 4,750,000
Signature date(s)
8/07/2021 : € 4,750,000
Link to source
Data sheet
Other links
News & Stories
Link to source
Other links
Inside the project
How and Why
Accessible health products and vaccines produced in Africa
Why
- Fewer than 2% of the three billion vaccine doses administered globally have been in Africa
- New manufacturing facilities on the continent are essential, as Africa currently imports 99% of its vaccines
- The COVID-19 pandemic highlighted the need to increase vaccination in Africa
How
- The vaccine production facility at the Institut Pasteur de Dakar plans to produce as many as 25 million doses of an approved COVID-19 vaccine a month by the end of 2022
- Improve investment in Africa’s health sector and boost the production and accessibility of heath products and technologies
- Support technology transfer and the creation of regional vaccine manufacturing hubs in other regions of Africa
Sectors & Countries
Story
A COVID-19 vaccine of its own for Africa
To increase vaccination rates, Africa needs to secure more doses. New manufacturing facilities on the continent are essential, as Africa currently imports 99% of its vaccines. The new vaccine production facility at the Institut Pasteur de Dakar is a key link in a vaccine strategy developed by the African Union and the Africa Centres for Disease Control and Prevention.
“Not only does this reinforce the health system, but also through this particular project it will create jobs, develop capacities in terms of knowhow and workforce, while bringing in new technology,” says Sall.
"It’s very important that we have this solidarity between African countries and European countries because it helps to build up a global ecosystem for global health security."
Related media
Health Solutions: Searching for the magic pills
Vaccines get all the attention, but COVID treatments for people who get sick are just as important to end this pandemic
Health Solutions: Why risky ideas are good in a crisis
To end the pandemic and avoid future problems, we must stop being afraid of risk and start innovating in COVID vaccines and all types of other research
A COVID-19 vaccine of its own for Africa
Europe backs COVID-19 vaccine production in Africa with an investment in Senegal’s Institut Pasteur de Dakar.
What’s the impact of an impact investment?
A study supported by the EU bank examines how an impact investment is contributing to improved maternal health services for Senegalese women
Links
Related projects and stories
New platform to boost support for EU regions most affected by the war in Ukraine
Tomorrow, the Commission will be hosting the launch of a new initiative to provide easier access to lending support to EU Member States bordering Russia, Belarus and Ukraine. This initiative, titled ‘EastInvest Facility', is at the core of the strategy for the EU's eastern regions bordering Russia, Belarus and Ukraine adopted last week by the Commission to help these regions tackle the challenges they face in the wake of Russia's war of aggression against Ukraine.
Superpower Europe
From clean energy to defence and innovation, Europe is reinforcing its economic and strategic strength through investment, integration and global partnerships.
Better Schools for All initiative kicks off a new chapter in Montenegrin education sector
Under the European Investment Bank (EIB Global) and United Nations Office for Project Services (UNOPS) Enhancing School Infrastructure in Montenegro project, a nationwide assessment of 813 pre-school, primary and secondary schools in Montenegro has officially begun. Experts have launched the first site visits in Podgorica, marking the start of a comprehensive effort to check the quality, safety and inclusiveness of education facilities and ensure modern learning environments for pupils and teachers across the country.